Pharmaceutical manufacturers should stop being overly cautious about the risks of closed systems and consider the benefits they could bring to patient care, according to David Estapé of CRB Group. He argues that companies can often overstate the risks posed by minuscule factors, disregarding the benefits closed systems could bring to delivery. Regulators also hamper progress by prolonging approval processes, Estapé added.
Getting the right information to patients without adding clinical, IT burdens
Advocate Health launched a personalized digital health journey to enhance patient engagement through automation and integration with its Epic EHR system, resulting in a 30%
